538
W.D. Clark et al. / Journal of Organometallic Chemistry 751 (2014) 534e540
through activated alumina [20]. 1,3-Bis(imidazol-10-yl)benzene (1),
1,3-bis(30-butylimidazol-10-yl)benzene diiodide (2a), 2-(1,3-bis(30-
butyl-imidazol-20-ylidene)phenylene)(dimethylamido)(diiodo)
zirconium (IV) (3a), and 2-(1,3-bis(30-butyl-imidazol-20-ylidene)
phenylene)tris(iodo) zirconium (IV) (5) were obtained via previ-
ously reported procedures [14aec,21]. Zr(NMe2)4 and Hf(NMe2)4
were freshly sublimed prior to use. All catalytic hydroamination/
cyclization reactions were performed in a screw cap NMR tube with
deuterated tol-d8 at 160 ꢀC.
CD2Cl2): d 192.4, 164.5, 147.7, 129.6, 121.9, 115.3, 110.5, 51.8, 43.3,
34.1, 20.4, 14.1.
4.5.1. Alternate procedure for 2-(1,3-bis(30-butyl-imidazol-20-
ylidene)phenylene)(dimethylamido)dichloro zirconium (IV) (3c)
1,3-Bis(30-butylimidazol-10-yl) benzene dichloride 2c (0.275 g,
0.696 mmol), Zr(NMe2)4 (0.190 g, 0.710 mmol), CH2Cl2 (15 mL) and
THF (6 mL) were combined, evacuated and stirred at room tem-
perature for 4 h. Approximately 70% of the solvent was removed in
vacuo resulting in the formation of a yellow precipitate. The pre-
cipitate was collected, washed with CH2Cl2 (5 mL) and hexanes
(3 ꢁ 5 mL) and dried in vacuo yielding a pale-yellow solid (0.083 g,
23%): Spectroscopic data of the solid was identical to Section 4.5.
Anal. Calcd For C22H31Cl2N5Zr: C, 50.08; H, 5.92; N, 13.27. Found: C,
49.98; H, 6.14; N, 12.85.
4.2. 1,3-Bis(30-butylimidazol-10-yl)benzene dibromide (2b)
1,3-Bis(imidazol-10-yl) benzene (3.73 g, 17.8 mmol), 1-
bromobutane (19.0 mL, 178 mmol) and acetonitrile (150 mL)
were combined in air and stirred at reflux for 3 h. After cooling to
room temperature, the volatiles were removed under reduced
pressure yielding a white solid (7.91 g, 92%): 1H NMR (CDCl3,
4.6. 2-(1,3-Bis(30-butyl-imidazol-20-ylidene)
phenylene)(dimethylamido)dibromo hafnium (IV) (4b)
300 MHz):
d
11.44 (s, 2H), 9.13 (s, 2H), 9.00 (s,1H), 8.36 (d, J ¼ 7.8 Hz,
2H), 7.64 (t, J ¼ 8.1 Hz,1H), 7.58 (s, 2H), 4.46 (s, 4H), 2.02 (s, 4H),1.44
(sex, J ¼ 7.8 Hz, 4H), 0.99 (t, J ¼ 7.6 Hz, 6H); 13C{1H} (75.5 MHz,
1,3-Bis(30-butylimidazol-10-yl) benzene dibromide 2b (0.594 g,
1.22 mmol), Hf(NMe2)4 (0.489 g, 1.34 mmol) and toluene (200 mL)
were combined in a sealing tube. The resulting mixture was soni-
cated for 20 min and then stirred at 160 ꢀC for 16 h. After cooling to
room temperature, a solid precipitated from the reaction mixture.
The precipitate was collected and dried under reduced pressure
yielding yellow-color crystals (0.443 g, 52%): 1H NMR (CD2Cl2,
CD2Cl2):
d 136.1, 135.9, 132.9, 122.9, 122.8, 122.6, 114.9, 50.6, 32.2,
19.7, 13.6.
4.3. 1,3-Bis(30-butylimidazol-10-yl)benzene dichloride (2c)
1,3-Bis(imidazol-10-yl) benzene (3.94 g, 18.7 mmol), 1-
chlorobutane (39.0 mL, 375 mmol) and acetonitrile (250 mL)
were combined and stirred for 24 h at 160 ꢀC in a sealed tube. After
cooling to room temperature, the volatiles were removed under
reduced pressure yielding a white solid (6.71 g, 91%): Spectroscopic
data of imidazolium salt 2c were identical to previously published
data [14d].
300 MHz):
d
7.51 (s, 2H), 7.27 (t, J ¼ 7.9 Hz, 1H), 7.14 (d, J ¼ 7.6 Hz,
2H), 7.07 (s, 2H), 4.41 (m, 2H), 4.30 (m, 2H), 3.06 (s, 6H), 1.93 (sex,
J ¼ 8.1 Hz, 4H), 1.46 (sex, J ¼ 7.5 Hz, 4H), 1.00 (t, J ¼ 7.3 Hz, 6H); 13
C
{1H} NMR (75.5 MHz, CD2Cl2):
d 199.6, 169.4, 147.2, 129.3, 122.0,
116.0, 110.8, 52.2, 44.2, 34.2, 20.3, 14.2. Anal. Calcd For
22H31Br2N5Hf: C, 37.54; H, 4.44; N, 9.95. Found: C, 37.32; H, 4.25;
C
N, 9.61.
4.4. 2-(1,3-Bis(30-butyl-imidazol-20-ylidene)
phenylene)(dimethylamido)dibromo zirconium (IV) (3b)
4.7. 2-(1,3-Bis(30-butyl-imidazol-20-ylidene)
phenylene)(dimethylamido)dichloro hafnium (IV) (4c)
1,3-Bis(30-butylimidazol-10-yl) benzene dibromide 2 (0.324 g,
0.669 mmol), Zr(NMe2)4 (0.197 g, 0.736 mmol) and toluene (40 mL)
were combined and stirred for 15 h at 160 ꢀC in a sealed tube. After
cooling to room temperature, a solid precipitated from the reaction
mixture. The precipitate was collected and dried under reduced
pressure yielding a yellow-color solid (0.273 g, 41%). A crystal
suitable for X-ray diffraction was selected from the solid. 1H NMR
1,3-Bis(30-butylimidazol-10-yl)benzene
dichloride
(2c)
(0.560 g, 1.41 mmol), Hf(NMe2)4 (0.563 g, 1.59 mmol) and
toluene (150 mL) were combined in a sealing tube. The mixture
was sonicated for 20 min and then stirred at 160 ꢀC for 15 h.
After cooling to room temperature, a solid precipitated from
the reaction mixture. The precipitate was collected and dried
under reduced pressure yielding a yellow-color solid (0.613 g,
(CD2Cl2, 500 MHz):
2H), 7.08 (br s, 2H), 4.44 (br s, 2H), 4.27 (br s, 2H), 2.95 (s, 6H), 1.92
d
7.49 (s, 2H), 7.27 (t, J ¼ 8.0 Hz, 1H), 7.09 (br s,
71%): 1H NMR (CD2Cl2, 300 MHz):
d 7.49 (s, 2H), 7.27 (t,
(br s, 2H), 1.90 (br s, 2H), 1.46 (sex, J ¼ 7.6 Hz, 4H), 1.00 (t, J ¼ 7.2 Hz,
6H); 13C{1H} NMR (125 MHz, CD2Cl2):
d 192.8, 164.9, 147.3, 129.4,
J ¼ 7.1 Hz, 1H), 7.14 (d, J ¼ 7.7 Hz, 2H), 7.05 (s, 2H), 4.39 (m,
2H), 4.26 (m, 2H), 3.04 (s, 6H), 1.92 (sex, J ¼ 6.8 Hz, 4H), 1.45
(sex, J ¼ 7.4 Hz, 4H), 1.00 (t, J ¼ 7.3 Hz, 6H); 13C{1H} NMR
121.8, 115.5, 110.6, 52.1, 43.1, 34.1, 20.4, 14.1. Anal. Calcd For
22H31Br2N5Zr: C, 42.86; H, 5.07; N, 11.36. Found: C, 42.68; H, 4.84;
C
N, 11.20.
(75.5 MHz, CD2Cl2):
d 198.7, 169.4, 147.6, 129.4, 122.0, 115.8,
110.7, 51.9, 44.7, 34.1, 20.3, 14.1.
4.5. 2-(1,3-Bis(30-butyl-imidazol-20-ylidene)
phenylene)(dimethylamido)dichloro zirconium (IV) (3c)
4.7.1. Alternate procedure for 2-(1,3-bis(30-butyl-imidazol-20-
ylidene)phenylene)(dimethylamido)dichloro hafnium (IV) (4c)
1,3-Bis(30-butylimidazol-10-yl)benzene dichloride (2c) (0.224 g,
0.567 mmol) was added to a solution of Hf(NMe2)4 (0.207 g,
0.583 mmol) in THF (10 mL). The mixture was sonicated for 3 min
and then allowed to sit undisturbed for 8 h. During this time a
yellow precipitate formed. The mixture was placed in a 4 ꢀC freezer
for 1 h and the supernatant liquid was decanted. The solid was
washed with toluene (2 mL), hexanes (2 ꢁ 2 mL) and dried in vacuo
yielding a yellow, microcrystalline powder (0.090 g, 26%). Anal.
Calcd For C22H31Cl2N5Hf: C, 42.97; H, 5.08; N, 11.39. Found: C, 41.84;
H 5.30; N, 11.08.
1,3-Bis(30-butylimidazol-10-yl) benzene dichloride 2c (0.195 g,
0.493 mmol), Zr(NMe2)4 (0.145 g, 0.542 mmol) and toluene
(100 mL) were combined in a sealing tube, sonicated for 20 min and
then stirred for 15 h at 160 ꢀC. After cooling to room temperature, a
solid precipitated from the reaction mixture. The precipitate was
collected and dried under reduced pressure yielding a yellow-color
micro-crystalline solid (0.081 g, 31%): 1H NMR (300 MHz, CD2Cl2):
d
7.48 (s, 2H), 7.28 (t, J ¼ 7.8 Hz, 1H), 7.10 (s, 2H), 7.07 (s, 2H), 4.43 (br
s, 2H), 4.27 (br s, 2H), 2.93 (s, 6H), 1.91 (br s, 2H), 1.90 (br s, 2H), 1.45
(sex, J ¼ 7.5 Hz, 4H), 1.00 (t, J ¼ 7.4 Hz, 6H); 13C{1H} NMR (75.5 MHz,